Literature DB >> 21533613

Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer.

Xiaoli Li1, Rui Lin, Jiansheng Li.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are a class of small (19-25 nucleotides) noncoding RNAs that regulate the expressions of a wide variety of genes, including some involved in cancer development. Some recent studies show that DNA methylation contributes to down-regulation of microRNA-375 (miR-375) during tumorigenesis. Whether or not down-regulation of miR-375 also exists in esophageal cancer is unknown. AIM: Our aim was to test the hypothesis that down-regulation of miR-375 also exists in esophageal cancer.
METHODS: Expression of levels of miR-375 were examined using real-time PCR on paired esophageal cancer and adjacent non-cancerous tissues. The methylation status is detected by methylation specific-PCR (MSP).
RESULTS: The results show that miR-375 is downregulated by hypermethylation of the promoter in esophageal cancer tissues. Epigenetic silencing of miR-375 induced an up-regulation of its targets, 3-phosphoinositide-dependent protein kinase-1 (PDK1). Restoration of the miR-375 expression in esophageal cancer cell lines downregulated the PDK1 expression. Furthermore, the miR-375 expression was found to be inversely correlated with PDK1 expression in esophageal cancer.
CONCLUSION: Thus, miR-375 is frequently down-regulated in esophageal cancer and is a negative regulator of PDK1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533613     DOI: 10.1007/s10620-011-1711-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Combinatorial microRNA target predictions.

Authors:  Azra Krek; Dominic Grün; Matthew N Poy; Rachel Wolf; Lauren Rosenberg; Eric J Epstein; Philip MacMenamin; Isabelle da Piedade; Kristin C Gunsalus; Markus Stoffel; Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2005-04-03       Impact factor: 38.330

2.  miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.

Authors:  Ming Liu; Nan Lang; Meng Qiu; Feng Xu; Qiu Li; Qiulin Tang; Ji Chen; Xi Chen; Siyuan Zhang; Zhen Liu; Jitao Zhou; Yajie Zhu; Yu Deng; Yi Zheng; Feng Bi
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

3.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.

Authors:  Yoshiyuki Tsukamoto; Chisato Nakada; Tsuyoshi Noguchi; Masato Tanigawa; Lam Tung Nguyen; Tomohisa Uchida; Naoki Hijiya; Keiko Matsuura; Toshio Fujioka; Masao Seto; Masatsugu Moriyama
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

4.  MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.

Authors:  Ling Ding; Yanjun Xu; Wei Zhang; Yujie Deng; Misi Si; Ying Du; Haomi Yao; Xuyan Liu; Yuehai Ke; Jianmin Si; Tianhua Zhou
Journal:  Cell Res       Date:  2010-06-15       Impact factor: 25.617

5.  MicroRNA expression in head and neck cancer associates with alcohol consumption and survival.

Authors:  Michele Avissar; Michael D McClean; Karl T Kelsey; Carmen J Marsit
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

6.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.

Authors:  Jian-Jun Zhao; Jianhong Lin; Tint Lwin; Hua Yang; Jianping Guo; William Kong; Sophie Dessureault; Lynn C Moscinski; Dorna Rezania; William S Dalton; Eduardo Sotomayor; Jianguo Tao; Jin Q Cheng
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

7.  MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma.

Authors:  Michele Avissar; Brock C Christensen; Karl T Kelsey; Carmen J Marsit
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

8.  Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.

Authors:  Ying Liu; Jingna Wang; Min Wu; Wuzhou Wan; Ronghua Sun; De Yang; Xiangjun Sun; Dalong Ma; Guoguang Ying; Ning Zhang
Journal:  Mol Cancer Res       Date:  2009-06-16       Impact factor: 5.852

9.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Authors:  Yannick Ladeiro; Gabrielle Couchy; Charles Balabaud; Paulette Bioulac-Sage; Laura Pelletier; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

10.  Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes.

Authors:  David K Finlay; Linda V Sinclair; Carmen Feijoo; Caryll M Waugh; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more
  41 in total

1.  The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.

Authors:  Rom S Leidner; Lakshmeswari Ravi; Patrick Leahy; Yanwen Chen; Beth Bednarchik; Mirte Streppel; Marcia Canto; Jean S Wang; Anirban Maitra; Joseph Willis; Sanford D Markowitz; Jill Barnholtz-Sloan; Mark D Adams; Amitabh Chak; Kishore Guda
Journal:  Genes Chromosomes Cancer       Date:  2012-02-03       Impact factor: 5.006

Review 2.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

3.  The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta-analysis.

Authors:  Peng Wang; LiangLiang Xu; Lian Li; ShengSheng Ren; JianWei Tang; Ming Zhang; MingQing Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-12       Impact factor: 2.503

4.  Methylation and microRNA-mediated epigenetic regulation of SOCS3.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

Review 5.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 6.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

7.  Long-term cisplatin exposure promotes methylation of the OCT1 gene in human esophageal cancer cells.

Authors:  Rui Lin; Xiaoli Li; Jiansheng Li; Lianfeng Zhang; Feng Xu; Yanjun Chu; Jichang Li
Journal:  Dig Dis Sci       Date:  2012-10-06       Impact factor: 3.199

8.  Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis.

Authors:  Saskia M Wilting; Wina Verlaat; Annelieke Jaspers; Nour A Makazaji; Reuven Agami; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen
Journal:  Epigenetics       Date:  2013-01-16       Impact factor: 4.528

9.  An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer.

Authors:  Jiaxuan Liu; Ping Wang; Ping Zhang; Xinyu Zhang; Hang Du; Qiang Liu; Bo Huang; Caiyun Qian; Shuhua Zhang; Weifeng Zhu; Xiaohong Yang; Yingqun Xiao; Zhuoqi Liu; Daya Luo
Journal:  J Appl Genet       Date:  2019-08-01       Impact factor: 3.240

Review 10.  DNA methylation and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Mol Oncol       Date:  2012-08-10       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.